A study of the evaluation of clinically diagnostic efficiency of detecting hepatocellular carcinoma in HBV-liver cirrhosis by multiple imaging techniques

Status

Active, not recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-DDT-09000467

Enrollment

Unknown

Registered

2009-05-18

Start date

2008-07-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular carcinoma in liver cirrhosis

Interventions

Gold Standard:

Index test:

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. The patient underwent both MR and MDCT during one month 2. There are focal hepatic lesions at MDCT or MR with a complete diagnosis report; 3. The patient hasn't accepted any surgery or intervention therapy; 4. Serum AFP>100 unit; or ultrasound shows nodule(s) in liver, the diameter of a single nodule <3 cm or the total diameter of 2-3 nodules <5 cm.

Exclusion criteria

Exclusion criteria: 1. Pregnant woman or breast feeding woman; 2. Patient with serious organ failure; 3. Patient with mild to severe damage of renal function, defined as GFR/eGFR<60mL/min; 4. Patient with pacemaker, heart valve or other implants which cannot approach strong magnetic field; 5. Severe claustrophobe; 6. Patient with concomitant disease who may not complete the examination.

Design outcomes

Primary

Measure	Time frame
lesion existence;Specificity, Sensitivity;Accuracy;lesion malignancy;	—

Countries

China

Contacts

Public ContactXiaoying Wang

cjr.wangxiaoying@vip.163.com+86 10 66551122-2097

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026